Total Valuation
Biotron has a market cap or net worth of $3.91M. The enterprise value is $6.55M.
Market Cap$3.91M
Enterprise Value$6.55M
Share Statistics
Biotron has 2,785,205,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding2,785,205,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Biotron ’s return on equity (ROE) is -0.52 and return on invested capital (ROIC) is -49.02%.
Return on Equity (ROE)-0.52
Return on Assets (ROA)-0.41
Return on Invested Capital (ROIC)-49.02%
Return on Capital Employed (ROCE)-0.66
Revenue Per Employee0.00
Profits Per Employee-379.58K
Employee Count4
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Biotron is ―. Biotron ’s PEG ratio is 0.04.
PE Ratio―
PS Ratio0.00
PB Ratio2.13
Price to FCF-3.50
Price to Operating Cash Flow-2.81
PEG Ratio0.04
Income Statement
In the last 12 months, Biotron had revenue of 0.00 and earned -1.52M in profits. Earnings per share was 0.00.
Revenue0.00
Gross Profit-1.91K
Operating Income-1.93M
Pretax Income-2.04M
Net Income-1.52M
EBITDA-1.93M
Earnings Per Share (EPS)0.00
Cash Flow
In the last 12 months, operating cash flow was -1.92M and capital expenditures 0.00, giving a free cash flow of -1.92M billion.
Operating Cash Flow-1.92M
Free Cash Flow-1.92M
Free Cash Flow per Share>-0.01
Dividends & Yields
Biotron pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta21.99
52-Week Price Change31.25%
50-Day Moving Average0.03
200-Day Moving Average―
Relative Strength Index (RSI)27.67
Average Volume (3m)7.01K
Important Dates
Biotron upcoming earnings date is Mar 4, 2027, TBA (Confirmed).
Last Earnings DateAug 21, 2026
Next Earnings DateMar 4, 2027
Ex-Dividend Date―
Financial Position
Biotron as a current ratio of 1.94, with Debt / Equity ratio of 0.00%
Current Ratio1.94
Quick Ratio1.94
Debt to Market Cap0.00
Net Debt to EBITDA0.81
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Biotron has paid -525.87K in taxes.
Income Tax-525.87K
Effective Tax Rate0.26
Enterprise Valuation
Biotron EV to EBITDA ratio is -2.42, with an EV/FCF ratio of -2.63.
EV to Sales0.00
EV to EBITDA-2.42
EV to Free Cash Flow-2.63
EV to Operating Cash Flow-2.63
Balance Sheet
Biotron has $1.64M in cash and marketable securities with $0.00 in debt, giving a net cash position of $1.64M billion.
Cash & Marketable Securities$1.64M
Total Debt$0.00
Net Cash$1.64M
Net Cash Per Share<$0.01
Tangible Book Value Per Share<$0.01
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Biotron is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast-200.00%